Tamona® (Tamoxifen) is a non-steroidal, triphenylene-based antineoplastic drug . In breast cancer patients, at the tumour level, Tamoxifen acts primarily as an antioestrogen, preventing oestrogen binding to the oestrogen receptor. If used to the right pa
Tamona Tablet 20mg
Reduction of breast cancer incidence in women at high risk: 20 mg daily for 5 year.
Breast cancer: 20 mg daily as a single or in 2 divided doses. Max: 40 mg daily.
Anovulatory infertility: 20 mg daily on days 2-5 of the menstrual cycle, increase if necessary in subsequent cycles. Max: 80 mg daily. Women w/ irregular menstruation: Initial course may begin on any day and a 2nd course may start 45 days later.